LY2874455 potently inhibits FGFR gatekeeper mutants and overcomes mutation-based resistance.
Wu, D., Guo, M., Min, X., Dai, S., Li, M., Tan, S., Li, G., Chen, X., Ma, Y., Li, J., Jiang, L., Qu, L., Zhou, Z., Chen, Z., Chen, L., Xu, G., Chen, Y.(2018) Chem Commun (Camb) 54: 12089-12092
- PubMed: 30298149 
- DOI: https://doi.org/10.1039/c8cc07546h
- Primary Citation of Related Structures:  
5XFF, 5XFJ - PubMed Abstract: 
The chemical compound LY2874455 has the potential to overcome drug resistance driven by FGFR gatekeeper mutations. X-ray crystallographic studies provide the structural explanation for why this compound is effective against the FGFR gatekeeper mutations.
Organizational Affiliation: 
Laboratory of Structural Biology, Key Laboratory of Cancer Proteomics of Chinese Ministry of Health, XiangYa Hospital, Central South University, Changsha, Hunan 410008, China. yonghenc@163.com.